|Place of Origin:||China|
|Brand Name:||Senwayer Brand|
|Certification:||ISO, 9001, USP|
|Minimum Order Quantity:||10g|
|Price:||Discount is possible if your order is big enough|
|Packaging Details:||10g, 20g, 50g , 100g, 500g. 1kg, 10kg|
|Delivery Time:||within 2 working days|
|Payment Terms:||T/T in advance, Money Gram, Western Union, Bank Transfer.|
|Supply Ability:||50KG / Month|
|CAS:||235114-32-6||Alias:||Micafungin , Micafungin-d11, FK-463|
|Apparence:||Almost White Crystalline Powder||Purity:||99.5%|
|Grade:||Pharma Grade||Function:||Anti-tumor Drugs|
pharmaceutical raw material,
medical raw material
Medical Raw Material Drug Anti-tumor Micafungin / FK-463 CAS 235114-32-6 Powder
|Synonyms:||MICAFUNGIN;Micafungin (Acid);PneuMocandin A0,1-[(4R,5R)-4,5-dihydroxy-N2-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]-;Micafungin-d11|
|Product Categories:||Antifungals;Aromatics;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API|
Micafungin (trade name Mycamine) is an echinocandin antifungal drug developed by Astellas Pharma. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
Micafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1999 from Fujisawa in Japan. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379 which contains a phenolic sulfate to enhance aqueous solubility, a serious limitation in the class. Micafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensively referenced in the literature with over 700 citations.
Medical Application API:
This medication is used to treat a variety of fungal infections (such as candidemia, esophageal candidiasis). It is also used to prevent fungal infections if you are having a bone marrow or stem cell transplant, since people with weak immune systems have a higher risk of fungal infections.
Micafungin belongs to a class of drugs known as echinocandins. It works by stopping the growth of fungus.
Usage An echinocandin antifungal drug which inhibits the synthesis of 1,3-β-D-glucan, an essential component of the fungal cell wall, and represent a valuable treatment option for fungal infections.
Usage Micafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1999 from Fujisawa in Japan. Unlike other marketed semi-synthetic derivatives in this class,
micafungin is not derived from echinocandin but rather from FR901379 which contains a phenolic sulphate to enhance aqueous solubility, a serious limitation in the class.
Micafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensively referenced in the literature with over 700 citations.
How to use micafungin intravenous?
This medication is given by injection into a vein by a health care professional. It is usually given once a day. It should be injected slowly over 1 hour. The dosage and length of treatment is based on your medical condition and response to treatment. In children, the dosage is also based on weight.
If you are using this medication at home, learn all preparation and usage instructions from your health care professional.
Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid.
This medication is given by injection into a vein, as directed by your doctor, usually once a day. Rash, itchy skin, swelling of the face, dizziness, and low blood pressure may occur if this medication is given too quickly. Therefore, it is important to inject this medication slowly over 1 hour. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.